The Effect of Bismuth Potassium Citrate in the Treatment of HP Positive Peptic Ulcers and Its Impact on the Levels of Inflammatory Factors such as Hypersensitive C-reactive Protein and Interleukin-17 in Patients
Objective To explore and analyze the efficacy of bismuth potassium citrate in the treatment of Hp positive peptic ulcers and its impact on the levels of inflammatory factors such as hypersensitive C-reactive protein and inter-leukin-17 in patients.Methods Eighty patients with Hp positive peptic ulcers admitted to Renhuai People's Hospital from December 2023 to March 2024 were objectively selected as the study subjects.According to different treatment methods,they were divided into control group and observation group,with 40 cases in each group.The control group was treated with triple therapy,and the observation group was treated with triple therapy combined with bismuth so-dium citrate.The levels of inflammatory factor,incidence of adverse reactions,and total effective rate of treatment were compared between the two groups before and after treatment.Results After treatment,the hypersensitive C-reactive protein and interleukin-17 were lower in observation group compared to the control group.The incidence of adverse reactions in the observation group was lower than that in the control group,the differences were statistically significant(all P<0.05).The total effective rate of treatment was 95.00%(38/40),which was higher than the control group's 80.00%(32/40),the difference was statistically significant(χ2=4.114,P<0.05).Conclusion Potassium bis-muth citrate has a good therapeutic effect on Hp positive peptic ulcers,improving the levels of inflammatory factors in patients with minimal toxic side effects.It is worthy of clinical application.
万方数据
维普
